Companies which are more than 50% undervalued based on analyst price target.

기업	최종 가격	7일 수익률	1년 수익률	시가총액	애널리스트 목표가	가치평가	성장	배당 수익률	산업
HUBN 신규	CHF 170.00	1.1%	42.9%	CHF 3.1b	CHF 261.50	43.1	39.4%	1.2%	Capital Goods
NEAG	CHF 30.90	2.0%	-3.7%	CHF 1.0b	CHF 60.00	6.7	-14.1%	2.9%	Utilities
CMHC	CHF 57.10	-1.9%	-8.5%	CHF 974.7m	CHF 122.57	10.2	55.1%	3.5%	Pharmaceuticals & Biotech
KURN	CHF 21.68	-3.5%	-14.0%	CHF 842.6m	CHF 33.92	119.9	58.6%	n/a	Pharmaceuticals & Biotech
MEDX	CHF 8.82	-0.6%	-18.9%	CHF 362.7m	CHF 14.97	3590.3	64.6%	1.1%	Healthcare
MIKN	CHF 16.20	0.6%	-12.4%	CHF 275.3m	CHF 29.80	9.6	-1.0%	3.7%	Capital Goods
PEAN	CHF 4.89	6.4%	-27.6%	CHF 254.8m	CHF 7.87	2.0	104.4%	0%	Real Estate Management and Development
NWRN	CHF 12.60	0.2%	46.2%	CHF 254.2m	CHF 47.48	14.6	50.2%	n/a	Pharmaceuticals & Biotech
SANN	CHF 15.56	-5.8%	12.4%	CHF 238.8m	CHF 27.50	3.1	18.6%	n/a	Pharmaceuticals & Biotech
BIOV	CHF 24.70	-2.0%	-10.8%	CHF 148.4m	CHF 58.26	45.6	-14.2%	n/a	Pharmaceuticals & Biotech
MOLN	CHF 3.75	7.4%	25.4%	CHF 137.9m	CHF 9.00	2.5	4.9%	n/a	Pharmaceuticals & Biotech
VARN	CHF 13.35	1.1%	-31.9%	CHF 134.7m	CHF 25.18	1.5	7.0%	0%	Real Estate Management and Development
LMN	CHF 11.95	0%	-20.9%	CHF 126.8m	CHF 19.37	41.0	60.9%	3.2%	Consumer Services
XLS	CHF 13.80	-8.6%	-33.0%	CHF 82.1m	CHF 31.00	285.8	-6.9%	n/a	Pharmaceuticals & Biotech
MMTX	CHF 0.18	-4.8%	n/a	CHF 23.8m	CHF 2.73	42.9	87.7%	n/a	Pharmaceuticals & Biotech
ASWN	CHF 0.61	5.2%	-41.3%	CHF 8.7m	CHF 2.00	0.6	83.7%	n/a	Media

Top Stock Picks from Analysts